SOLID FORMS COMPRISING (+)-2-[1-(3-ETHOXY-4-METHOXYPHENYL)-2-METHYLSULFONYLETHYL]-4-ACETYLAMINOISOINDOLINE-1,3-DIONE, COMPOSITIONS THEREOF, AND USES THEREOF

PROBLEM TO BE SOLVED: To provide: a compound capable of treating and/or preventing disorders ameliorated by the reduction of levels of TNF-α or the inhibition of PDE4; and compositions comprising the compound.SOLUTION: Provided are (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2- methylsulfonylethyl]-4-acetyl...

Full description

Saved in:
Bibliographic Details
Main Authors MULLER GEORG W, PETER H SCHAFER, GE CHUANSHENG, XU JEAN, MAN HON-WAH
Format Patent
LanguageEnglish
Published 26.06.2014
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:PROBLEM TO BE SOLVED: To provide: a compound capable of treating and/or preventing disorders ameliorated by the reduction of levels of TNF-α or the inhibition of PDE4; and compositions comprising the compound.SOLUTION: Provided are (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2- methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione represented by the specified formula, solid forms comprising the compound, and compositions comprising the solid forms.
Bibliography:Application Number: JP20140016879